Post-CAR T Cell Therapy Lymphoproliferative Disorders Explained
Chimeric antigen receptor (CAR) T cell therapy is revolutionizing the treatment landscape of hematological malignancies, presenting a potent, targeted immunotherapeutic ...
Tag: CAR-T cell therapy complications
Mount Sinai Researchers Develop First Targeted Therapy for Rare T-Cell Lymphoma Following CAR T Treatment
In a landmark development at the forefront of hematologic oncology, researchers from The Tisch Cancer Institute at the Icahn School ...
May 19, 2025: Key Research Breakthroughs at MSK
Recent breakthroughs from the Memorial Sloan Kettering Cancer Center (MSK) have shed light on crucial aspects of cancer biology and ...
Uncommon Adverse Reaction Found in Cancer Immunotherapy Treatments
In the evolving landscape of cancer treatment, particularly concerning hematological malignancies such as multiple myeloma and lymphoma, Car-T cell therapy ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!